chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe calf muscle cramps, possible blood clot; Severe calf muscle cramps, possible blood clot; This is a spontaneous report from a contactable other hcp.  A 28-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 24Mar2021 12:00 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. Medical history was reported as "none". The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. the patient previously received the first dose of BNT162B2 on 26Feb2021 at 10:00 administered in the left arm for COVID-19 immunization. The patient's concomitant medications were not reported. The patient experienced severe calf muscle cramps, possible blood clot on 01Apr2021 12:00. The outcome of events was not recovered.  Patient did not receive any treatment for the events.   Follow up needed, further information has been requested; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. Case will be reassessed upon receipt of follow-up information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Headaches, eyelid swelling, slight swelling and tenderness around injection sites. Pt states "I just don't feel well", joint and muscle pain. CBC, CMP and UA labs were done, results were within normal limits. Pt was prescribed Prednisone taper 40mg x3 days, 20mg x 3 days. Pt instructed to go to hospital ER if conditions worsen.
Patient received flu vaccine (he was standing by mom while seeing his younger sibling receive the flu shot) and shortly fell to floor resulting with a bump on side of forehead. He was conscious the entire time answering all questions being asked of him and placed ice pack on bump immediately. (Swelling went down before he was pushed in motor chair to car). He also had some water. He said his head hurt and parents took him to visit dr right away. We offered to call ambulance, however they said it was not necessary. I followed up with mom at 11:30 and then 12:30. They had just left dr office and dr said he had a concussion to only give Tylenol and refrain from sports this week, but that he would be ok. Dr. said he had fainting episode due to possibly watching brother get vaccine administered. Mom said he would be fine and I told her I would continue following up with her throughout the week.
Hospitalized for what was determined with Guillain Barre -Miller Fischer Syndrome.  Symptoms slowly started a couple weeks after the vaccine and eventually worsened to the point of not being able to open my mouth. Symptoms included facial paralysis, Muscle weakness, fatigue, vision issues, Neuropathy issues. I was transfused with multiple doses of Immunoglobulin and IV steroids. Still currently in Physical therapy I have lost 3 months of not being able to work. Also had a blood clot
Throbbing headache; Fatigue; Chills; Muscle pain; Joint pain; Back pain; Soreness on left arm where injection occurred; Limited mobility on left arm where injection occurred; Mild fever; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 09.00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit-hyperactivity disorder (ADHD). The patient had no known allergies to medications, food or other products. Concomitant medications included ethinylestradiol, norgestimate (SPRINTEC) for birth control, alprazolam (XANAX) 1mg and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALLXR) 30mg from unknown date for unknown indication received within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 21.00,12 hours after first dose of vaccine, the patient experienced throbbing headache, fatigue, chills, muscle pain, joint pain, back pain, soreness and limited mobility on left arm where injection occurred and mild fever persisted for approximately 4 days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of throbbing headache, fatigue, chills, muscle pain, joint pain, back pain, soreness and limited mobility on left arm where injection occurred, mild fever were recovered on 21Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
patient received her vaccines and started to feel lightheaded. After a few seconds she fainted and fell out of the chair she was vaccinated in and hit her head.
pt recvd vax & devel pain in lt knee joint; 18NOV92 lab eval showed anti-HBs neg;
Pt with a pulmonary embolism 4 days post vaccine.  Diagnosed in our ED.
Myocarditis Presented to ED with 2 days of chest pain, back pain, and nausea and vomiting 1 day after receiving Pfizer vaccine. Patient initially had back pain starting the night of 7/24, sudden onset. The next day she began to complain of stabbing chest pain that radiated into her left arm. Outside ED found elevated troponin of 2.93 and transferred to the hospital.   Patient was COVID negative on admission and remained afebrile throughout her hospital stay. Patient was given IVIG on 7/27 which was well-tolerated, did not require steroid treatment. Cardiac markers downtrended over course of admission and was discharged 7/29 after normal Echo with Cardiology follow up.
Hep B (3rd dose) give 05/13/03 in right deltoid.  Noticed itching, splotchy rash on right arm and right neck 5 days later.  Later noticed same in left arm.  Soreness in right arm.
Patient c/o severe swelling of (L) arm after receiving influenza vaccine on 3/8/12. She described it as red, sore & swollen for 5 days. Reports fever & headaches 2-3 days after receiving vaccine. Pt took anti inflammatory med to relieve pain & swelling. Today arm is not swollen, but severe bruising from deltoid to elbow. Able to move arm freely, no fever, & denies pain. Continue to feel weak.
after a below freezing temperature excursion; This case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a 9-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number mk944, expiry date 5th March 2023) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 16th July 2021, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.    his report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The physician reported that, the patient was administrated with Pediarix after a below freezing temperature excursion, which led to incorrect storage of drug. No adverse event was reported. The reporter consented to follow up. This case was 1 of 29 linked cases,reported by same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021164777:same reporter US-GLAXOSMITHKLINE-US2021164791:same reporter US-GLAXOSMITHKLINE-US2021164781:same reporter US-GLAXOSMITHKLINE-US2021164775:same reporter US-GLAXOSMITHKLINE-US2021164771:same reporter US-GLAXOSMITHKLINE-US2021164769:same reporter US-GLAXOSMITHKLINE-US2021164779:same reporter US-GLAXOSMITHKLINE-US2021164784:same reporter US-GLAXOSMITHKLINE-US2021164786:same reporter US-GLAXOSMITHKLINE-US2021164787:same reporter US-GLAXOSMITHKLINE-US2021164788:same reporter US-GLAXOSMITHKLINE-US2021164789:same reporter US-GLAXOSMITHKLINE-US2021164791:same reporter US-GLAXOSMITHKLINE-US2021164792:same reporter US-GLAXOSMITHKLINE-US2021164793:same reporter US-GLAXOSMITHKLINE-US2021164794:same reporter US-GLAXOSMITHKLINE-US2021164795:same reporter US-GLAXOSMITHKLINE-US2021164797:same reporter US-GLAXOSMITHKLINE-US2021164798:same reporter US-GLAXOSMITHKLINE-US2021164799:same reporter US-GLAXOSMITHKLINE-US2021164800:same reporter US-GLAXOSMITHKLINE-US2021164801:same reporter US-GLAXOSMITHKLINE-US2021164802:same reporter US-GLAXOSMITHKLINE-US2021164803:same reporter US-GLAXOSMITHKLINE-US2021164804:same reporter US-GLAXOSMITHKLINE-US2021164805:same reporter US-GLAXOSMITHKLINE-US2021164806:same reporter US-GLAXOSMITHKLINE-US2021164808:same reporter US-GLAXOSMITHKLINE-US2021164800:
Patient states she received the Moderna 2 shot series in June 2021.  Has not received a booster.
Skin peeled the next day, dried out, became rough, and faded to white.  Now I have vitiligo.
Administration of Infanrix instead of Boostrix for 11 year old; Administration of Infanrix instead of Boostrix for 11 year old; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-year-old female patient who received DTPa (Infanrix) (batch number 49TM3, expiry date 28th May 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 29th March 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 29th March 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced adult use of a child product. On an unknown date, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration and adult use of a child product were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter reported administration of Infanrix instead of Boostrix for 11 year old, which led to inappropriate age at vaccine administration. Consented to follow up
COVID 19 treatment; COVID 19 treatment; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 33 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing), notes: Known allergies: Sulfa; "Known allergies: Iodine contrast" (unspecified if ongoing), notes: Known allergies: Iodine contrast; "Known allergies: Latex" (unspecified if ongoing), notes: Known allergies: Latex. Concomitant medication(s) included: ACETAMINOPHEN; TYLENOL; ADVIL [IBUPROFEN]. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID 19 treatment". Therapeutic measures were taken as a result of covid-19, drug ineffective.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on reported information, causal association of event drug ineffective, covid-19 with BNT162b2 cannot be excluded. However, response to vaccine can vary in individuals.
The evening after the injection chills, fever and fatigue for 48 hours..  Fatigue continued for a week then the following Wednesday after the vaccination on March 3rd. Chest pains began with shortness of breath at  about 6pm.   Went to the hospital that evening and had xrays and echo which showed signs of fluid and inflammation in the pleural sac.  Diagnosis Plurisy.  Patient had no history of lung issues or recent sickness other that the vaccination.
Rash like bumps on arms and nose and cheeks. Not red just small all-over bumps that are itchy and painful
on Saturday, March 27th, patient noticed swelling in left lower leg with Shortness of breath, and heart racing.  on 3/39, the patient presented to the ED and was admitted and diagnosed with a blood clot from left groin to left ankle, with "clot in heart and lungs".  heparinized and discharged home on Coumadin currently taking 5 mg on Sunday, Monday, Wednesday, and Saturday and 2.5 mg on Tuesday and Friday each week.
My arm hurt really bad that night and the next day. But then started to get better. But then I started to have unexpected pain in my arm and it hurts where the shot was administered. The pain has gotten worse and more frequent.
Headache; Fatigue; Joint Pain; Red eyes; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 19-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: unknown) via an unspecified route of administration, administered in Arm Left on 19Apr2021 at 19:45 (at the age of 19-years-old) as a dose 1, single for COVID-19 immunization. The patient medical history included asthma and ehlers danlos syndrome from an unspecified date and unknown if was ongoing. There were no concomitant medications. Historical vaccine included Meningitis Vaccine (Lot Number: unknown), via an unspecified route of administration on unspecified date followed with the reaction of Known allergies to the Meningitis Vaccine. The patient did not receive any other vaccine within 4 weeks. The patient did not have any other medications in two weeks. Reportedly, patient did not have any COVID prior vaccination. Patient was not tested for covid post vaccination. On 20Apr2021 at 12:00, patient experienced headache, fatigue, joint pain and red eyes. The patient did not receive any treatment for the events. Outcome of all the events were not resolved.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Within two hours, I started feeling slightly nauseous and lightheaded. Overnight, I woke up with a 100.5 degree fever. I had chills at the time and a sore throat. By midmorning the next day the nausea and fever went away. I felt very fatigued the whole next day. By the second day after the vaccine I felt fine.
he is coughing a lot; This is a spontaneous report from a contactable consumer (friend). A 37-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0185), via an unspecified route of administration on 21May2021 (at the age of 37-year-old) as dose 2, single for COVID-19 immunization. There were no medical history and concomitant medications. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown), via an unspecified route of administration on an unspecified date for COVID-19 immunization. The patient got vaccinated second dose like two days ago, on 21May2021(Friday) and he was coughing a lot (May2021). The reporter checked side effect leaf and it didn't appear coughing, so the reporter was kind of worry. The patient took Ibuprofen as treatment for cough. Reporter stated about weight as, "He was around 62 kg, No Sorry 92." The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Received the Maderna Covid Vaccine. I experienced flu-like body aches including headache the next day. The following day I developed itchiness and swelling at injection site, but my other symptoms improved greatly.
I arrived home from work on that Saturday evening and it started with a small prickle on the right side of my neck. All of a sudden it flared to a red, hot, burning sensation around my ear. About 15 minutes later I began swelling, itching, and red hives on the scalp of my head, back of my neck and completely the right side of my body. All the way to my feet. On Monday I went to a walk-in clinic and they gave me cortisol. I went to the doctor on Tuesday she referred me to a dermatologist who I just saw today. They did a blood work panel and they just gave me some medications to help calm down the hives. They did blood work, IEG allergen panel and I tested positive for an allergy reactive for dog and cat dander, however IEG was elevated to 229. I will have another test on Tuesday with the allergist.
Shortness of breath, heart racing, weak legs, symptoms of myocarditis, weak, tiredness
Mother describes that at 9:30 p.m. on the date of receiving the flu vaccine, patient woke up with a fever of 102.4 and was experiencing chills. Mother administered tylenol for fever. Patient woke up in the morning afebrile.
Stabbing pain in arm, not able to lift or move arm well for over 3 days symptoms started night of injection. On day three started treating symptoms with ice pack and TYLENOL. Patient after a few hours had minor relief from pain but is planning to contact primary care provider within 24 hours (day 4) if symptoms do not rapidly improve.
4/11/21: Was treated by a Primary Care Physician (PCP) - Moderate Heart Chest Pain. Monitoring.  5/16/21: Treated at Urgent Care - Dizziness, fainting symptoms, cough. Given prescription for cough.  5/18/21:  Annual Exam with PCP - Dizziness, Losing Balance, Cough, Fatigue, Wheezing - Treated for symptoms 6/26/21: Treated at Urgent Care - Cough, Sore throat, Congestion - Treated 6/28/21: Hospital Admission  - Diagnosed with  Pulmonary Embolism
Information has been received from a man concerning his grandmother who was vaccinated with pneumococcal vaccine 23 polyvalent. Subsequently, the pt experienced severe swelling in the arm. The pt was seen by a physician. She was told to take 2 Tylesnol. When the swelling did not subside, the pt was taken to the ER. No further information is available.
arm sore for 2 days, then severe jabbing pain in head the day after vaccine.  The next day, he had bad headaches when he moved his head.  Then the next day, 4 days after the shot, he got severe shingles rash on shoulder, back, chest
Infection; This is a spontaneous report received from a contactable reporter, Consumer, for a Pfizer sponsored program (159558). The reporter is the patient's grandmother.  An adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications as the patient was on a blood thinner. The following information was reported: INFECTION (hospitalization), outcome "unknown", described as "Infection". The grandmother stated that her adult granddaughter received 1st dose of the Pfizer COVID vaccine and became ill because of an infection and was sent to a hospital.  It was closer to 6-7 months after the first dose. She would like to know if her granddaughter needed to repeat 1st dose or can she get second dose at this point.  The lot number for bnt162b2 was not provided and will be requested during follow up.
swelling underneath eyes; Covid vaccine side-effects; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): GL-042822-11107 (Company).  A 42-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and in Jul2021 as dose 2, single (Batch/Lot number: unknown) at the age of 42 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: ADVERSE EVENT (non-serious) with onset Jul2021, outcome "unknown", described as "Covid vaccine side-effects"; PERIORBITAL SWELLING (non-serious) with onset 29Apr2022, outcome "unknown", described as "swelling underneath eyes".  Additional information: Patient had injection under eyes 26Oct2021 and had swelling the same day that lasted four months, starting from the date of injection. The swelling improved after four months; but today 29Apr2022, woke up with a little swelling underneath eyes again. Patient received Pfizer Covid vaccine on an unknown date for first vaccination, Jul2021 for 2nd vaccination. Patient also stated she had Covid vaccine side-effects in July, Aug and Sep2021.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
9 days after the shot had difficulty swallowing, like my throat was closing up, but no sore throat. I had a cold at the time, so was hard to tell if it was just some response to nasal drainage. 10 days after the shot an abnormal amount of itching. 11 days after the shot hives started appearing, particularly around hands and wrists days 12-16+ When not on a steady dose of Benadryl, hives and extreme burning in hands and sometimes feet. Roving hives that show up in one place with intense itching for 30 minutes, fade, and show up elsewhere.